These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 25275135)

  • 61. Identification of specific determinants of human APOBEC3F, APOBEC3C, and APOBEC3DE and African green monkey APOBEC3F that interact with HIV-1 Vif.
    Smith JL; Pathak VK
    J Virol; 2010 Dec; 84(24):12599-608. PubMed ID: 20943965
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Vif determines the requirement for CBF-β in APOBEC3 degradation.
    Yoshikawa R; Takeuchi JS; Yamada E; Nakano Y; Ren F; Tanaka H; Münk C; Harris RS; Miyazawa T; Koyanagi Y; Sato K
    J Gen Virol; 2015 Apr; 96(Pt 4):887-892. PubMed ID: 25516542
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Fab-based inhibitors reveal ubiquitin independent functions for HIV Vif neutralization of APOBEC3 restriction factors.
    Binning JM; Smith AM; Hultquist JF; Craik CS; Caretta Cartozo N; Campbell MG; Burton L; La Greca F; McGregor MJ; Ta HM; Bartholomeeusen K; Peterlin BM; Krogan NJ; Sevillano N; Cheng Y; Gross JD
    PLoS Pathog; 2018 Jan; 14(1):e1006830. PubMed ID: 29304101
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Small molecules that inhibit Vif-induced degradation of APOBEC3G.
    Matsui M; Shindo K; Izumi T; Io K; Shinohara M; Komano J; Kobayashi M; Kadowaki N; Harris RS; Takaori-Kondo A
    Virol J; 2014 Jul; 11():122. PubMed ID: 24986077
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Catalytic activity of APOBEC3F is required for efficient restriction of Vif-deficient human immunodeficiency virus.
    Albin JS; Brown WL; Harris RS
    Virology; 2014 Feb; 450-451():49-54. PubMed ID: 24503066
    [TBL] [Abstract][Full Text] [Related]  

  • 66. CBFβ stabilizes HIV Vif to counteract APOBEC3 at the expense of RUNX1 target gene expression.
    Kim DY; Kwon E; Hartley PD; Crosby DC; Mann S; Krogan NJ; Gross JD
    Mol Cell; 2013 Feb; 49(4):632-44. PubMed ID: 23333304
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The APOBEC3C crystal structure and the interface for HIV-1 Vif binding.
    Kitamura S; Ode H; Nakashima M; Imahashi M; Naganawa Y; Kurosawa T; Yokomaku Y; Yamane T; Watanabe N; Suzuki A; Sugiura W; Iwatani Y
    Nat Struct Mol Biol; 2012 Oct; 19(10):1005-10. PubMed ID: 23001005
    [TBL] [Abstract][Full Text] [Related]  

  • 68. HIV-1 restriction by endogenous APOBEC3G in the myeloid cell line THP-1.
    Ikeda T; Molan AM; Jarvis MC; Carpenter MA; Salamango DJ; Brown WL; Harris RS
    J Gen Virol; 2019 Jul; 100(7):1140-1152. PubMed ID: 31145054
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Status of APOBEC3G/F in cells and progeny virions modulated by Vif determines HIV-1 infectivity.
    Yamashita T; Nomaguchi M; Miyake A; Uchiyama T; Adachi A
    Microbes Infect; 2010 Feb; 12(2):166-71. PubMed ID: 19944180
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Defining HIV-1 Vif residues that interact with CBFβ by site-directed mutagenesis.
    Matsui Y; Shindo K; Nagata K; Io K; Tada K; Iwai F; Kobayashi M; Kadowaki N; Harris RS; Takaori-Kondo A
    Virology; 2014 Jan; 449():82-7. PubMed ID: 24418540
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Genetic and functional characterization of HIV-1 Vif on APOBEC3G degradation: First report of emergence of B/C recombinants from North India.
    Ronsard L; Raja R; Panwar V; Saini S; Mohankumar K; Sridharan S; Padmapriya R; Chaudhuri S; Ramachandran VG; Banerjea AC
    Sci Rep; 2015 Oct; 5():15438. PubMed ID: 26494109
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Identification of HIV-1 Vif regions required for CBF-β interaction and APOBEC3 suppression.
    Wang H; Liu B; Liu X; Li Z; Yu XF; Zhang W
    PLoS One; 2014; 9(5):e95738. PubMed ID: 24810617
    [TBL] [Abstract][Full Text] [Related]  

  • 73. CBFß and HIV Infection.
    Kim DY; Gross JD
    Adv Exp Med Biol; 2017; 962():415-431. PubMed ID: 28299671
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Polymorphisms of the cytidine deaminase APOBEC3F have different HIV-1 restriction efficiencies.
    Mohammadzadeh N; Follack TB; Love RP; Stewart K; Sanche S; Chelico L
    Virology; 2019 Jan; 527():21-31. PubMed ID: 30448640
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The resistance of human APOBEC3H to HIV-1 NL4-3 molecular clone is determined by a single amino acid in Vif.
    Ooms M; Letko M; Binka M; Simon V
    PLoS One; 2013; 8(2):e57744. PubMed ID: 23469063
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Structural Insights into HIV-1 Vif-APOBEC3F Interaction.
    Nakashima M; Ode H; Kawamura T; Kitamura S; Naganawa Y; Awazu H; Tsuzuki S; Matsuoka K; Nemoto M; Hachiya A; Sugiura W; Yokomaku Y; Watanabe N; Iwatani Y
    J Virol; 2016 Jan; 90(2):1034-47. PubMed ID: 26537685
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Polymorphisms in the APOBEC3G gene of Chinese rhesus macaques affect resistance to ubiquitination and degradation mediated by HIV-2 Vif.
    Jiang ZQ; Yao XR; Yu H; Lu YE; Liu BL; Liu FL; Jin YB; Zhuo M; Zheng YT; Ling F
    Arch Virol; 2019 May; 164(5):1353-1360. PubMed ID: 30859472
    [TBL] [Abstract][Full Text] [Related]  

  • 78. APOBEC3-mediated editing in HIV type 1 from pediatric patients and its association with APOBEC3G/CUL5 polymorphisms and Vif variability.
    De Maio FA; Rocco CA; Aulicino PC; Bologna R; Mangano A; Sen L
    AIDS Res Hum Retroviruses; 2012 Jun; 28(6):619-27. PubMed ID: 22145963
    [TBL] [Abstract][Full Text] [Related]  

  • 79. APOBEC3B Potently Restricts HIV-2 but Not HIV-1 in a Vif-Dependent Manner.
    Bandarra S; Miyagi E; Ribeiro AC; Gonçalves J; Strebel K; Barahona I
    J Virol; 2021 Nov; 95(23):e0117021. PubMed ID: 34523960
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Definition of the interacting interfaces of Apobec3G and HIV-1 Vif using MAPPIT mutagenesis analysis.
    Lavens D; Peelman F; Van der Heyden J; Uyttendaele I; Catteeuw D; Verhee A; Van Schoubroeck B; Kurth J; Hallenberger S; Clayton R; Tavernier J
    Nucleic Acids Res; 2010 Apr; 38(6):1902-12. PubMed ID: 20015971
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.